If you do not believe Radient told lies, just look at the resume for the head of their Oncology from 2010 to 2012.
"Director, Clinical & Scientific Writing/editing (Immunogene Therapy, Oncology)
Radient Pharmaceuticals Corp., Tustin, CA, USA May 2010–Apr 2012
•Lead writer/translator for 5 protocols, 5 CSRs, 5 CSS, 5 CSE, 5 CSO, 1 IND, 1 NDA
•Lead writer/translator for 23 slide decks, 6 posters, 9 abstracts, 2 manuscripts, 2 CME
•Sourced, hired and managed 3 internal and 8 external medical writers/editors
•Directed/executed clinical trials related to company’s oncology products
•Presented clinical trial data at 6 conferences, 5 exhibitions and 10 meetings
•Drafted/QCed 5 case reports, and updated/maintained study databases and pipeline drug compendia/dossier"
No IND's nor any NDA was ever submitted.
No clinical trials were ever run by Radient during this period.
I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.